A
Adrian T. Fung
Researcher at University of Sydney
Publications - 107
Citations - 1672
Adrian T. Fung is an academic researcher from University of Sydney. The author has contributed to research in topics: Medicine & Visual acuity. The author has an hindex of 18, co-authored 94 publications receiving 1201 citations. Previous affiliations of Adrian T. Fung include University of New South Wales & Thomas Jefferson University.
Papers
More filters
Journal ArticleDOI
Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration
TL;DR: Some patients presenting with Type 1 neovascularization may have clinical and multimodal imaging findings more consistent with long-standing central serous chorioretinopathy than with age-related macular degeneration.
Journal ArticleDOI
Visual and anatomical outcomes of intravitreal aflibercept in eyes with persistent subfoveal fluid despite previous treatments with ranibizumab in patients with neovascular age-related macular degeneration.
Nishant Kumar,Marcela Marsiglia,Marcela Marsiglia,Sarah Mrejen,Adrian T. Fung,Jason S. Slakter,John A. Sorenson,K. Bailey Freund,K. Bailey Freund +8 more
TL;DR: Intravitreal injections of aflibercept resulted in a significant improvement in visual and anatomical outcomes in eyes with persistent subfoveal fluid despite previous treatment with ranibizumab.
Journal ArticleDOI
Preparedness among Ophthalmologists: During and Beyond the COVID-19 Pandemic.
Ji-Peng Olivia Li,Jessica G. Shantha,Tien Yin Wong,Tien Yin Wong,Edmund Wong,J. S. Mehta,Haotian Lin,Xiaofeng Lin,Nicholas G. Strouthidis,Ki Ho Park,Adrian T. Fung,Stephen D. McLeod,Massimo Busin,David W. Parke,Gary N. Holland,James Chodosh,Steven Yeh,Daniel Shu Wei Ting,Daniel Shu Wei Ting +18 more
TL;DR: Preparedness among Ophthalmologists: During and Beyond the COVID-19 Pandemic Ji-Peng Olivia Li, MBBS, FRCOphth London, United Kingdom Jessica Shantha, MD* Atlanta, Georgia Tien Y. Wong, MD, PhD Singapore
Journal ArticleDOI
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.
Matias Iglicki,Catharina Busch,Dinah Zur,Dinah Zur,Mali Okada,Miriana Mariussi,Jay Chhablani,Zafer Cebeci,Samantha Fraser-Bell,Voraporn Chaikitmongkol,Aude Couturier,Ermete Giancipoli,Marco Lupidi,Patricio J. Rodríguez-Valdés,Matus Rehak,Adrian T. Fung,Adrian T. Fung,Adrian T. Fung,Michaella Goldstein,Michaella Goldstein,Anat Loewenstein,Anat Loewenstein,Anat Loewenstein +22 more
TL;DR: In this article, the efficacy and safety of repeated dexamethasone (DEX) implants over 24 months, in diabetic macular edema (DME) eyes that were treatment naive compared with eyes refractory to anti-vascular endothelial growth factor treatment, in a real-life environment.